Effect of a pharmaceutical cationic exchange resin on the properties of controlled release diphenhydramine hydrochloride matrices using methocel K4M or ethocel 7cP as matrix formers

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 899-908

  Akkaramongkolporn, Prasert ^a   Ngawhirunpat, Tanasait ^a   Nunthanid, Jurairat ^a   Opanasopit, Praneet ^a  

^a SILPAKORN UNIVERSITY   (Thailand)

Author keywords

Diphenhydramine hydrochloride; Ethylcellulose; Hydroxypropylmethylcellulose; Ion exchange resin; Matrix properties

Indexed keywords

DIPHENHYDRAMINE; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MAGNESIUM STEARATE; POLACRILIN;

ARTICLE; CATION EXCHANGE; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; GELATION; SURFACE PROPERTY; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET MATRIX; TABLET THICKNESS;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIPHENHYDRAMINE; ION EXCHANGE RESINS; METHYLCELLULOSE;

EID: 57149128892     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9129-6     Document Type: Article

References (32)

1. M. A. Holgado, I. Caraballo, J. Alvarez-Fuentes, M. J. Fernandez-Hervas, M. Fernandez-Arevalo, and A. M. Rabasco. Influence of diluents and manufacturing method on the in vitro dissolution of carteolol hydrochloride matrix tablets. Int. J. Pharm. 118:151-160 (1995).
2. N. Traconis, R. Rodriguez, M.E. Campos, and L. Villafuerte. Influence of admixed polymers on the metromidazole release from hydroxypropyl methylcellulose matrix tablets. Pharm. Acta. Helv. 72:131-138 (1997).
3. M. A. Dabbagh, J. L. Ford, and M. H. Rubinstein. Effects of polymer particle size, compaction pressure and hydrophilic polymers on drug release from matrices containing ethylcellulose. Int. J. Pharm. 140:85-95 (1996).
4. M. Sriwongjanya, and R. Bodmeier. Effect of ion exchange resins on the drug release from matrix tablets. Eur. J. Pharm. Biopharm. 46:321-327 (1998).
5. A. Streubel, J. Siepmann, A. Dashevsky, and R. Bodmeier. pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J. Control. Release. 67:101-110 (2000).
6. M. Tapia-Albarran, and L. Villafuerte-Robles. Assay of amoxicillin sustained release from matrix tablets containing different proportions of Carbopol 971P NF. Int. J. Pharm. 273:121-127 (2004).
7. H. Kranz, C. Guthmann, T. Wagner, R. Lipp, and J. Reinhard. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. Eur. J. Pharm Sci. 26:47-53 (2005).
8. R. V. Nellore, G. S. Rekhi, A. S. Hussain, L. G. Tillman, and L. L. Augsburger. Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration. J. Control. Release. 50:247-256 (1998).
9. N. Ramirez, L. M. Melgoza, M. Kuentz, H. Sandoval, and I. Caraballo. Comparison of different mathematical models for the tensile strength-relative density profiles of binary tablets. Eur. J. Pharm. Sci. 22:19-23 (2004).
10. K. A. Khan, and C. T. Rhodes. Water-sorption properties of tablet disintegrants. J. Pharm. Sci. 64:447-451 (1975).
11. S. Borodkin. Ion exchange resins and sustained release. In J. Swarbick, and J. C. Boylan (eds.), Encyclopedia of Pharmaceutical Technology, Marcel Dekker, New York, 1993, pp. 203-216.
12. D. B. Jack. Handbook of Clinical Pharmacokinetic Data, Macmillan, Great Britain, 1992.
13. Martindale the Extra Pharmacopoeia, Thirty-first edition, The Royal Pharmaceutical Society of Great Britain, London, 1996.
14. L. Genc, H. Bilac, and E. Guler. Studies on controlled release dimenhydrinate from matrix tablet formulations. Pharm. Acta. Helv. 74:43-49 (1999).
15. M. Ozyazici, E. H. Gokce, and G. Ertan. Release and diffusional modeling of metronidrazole lipid matrices. Eur. J. Pharm. Biopharm. 63:331-339 (2006).
16. The United States Pharmacopeia 24 and The National Formulary 19, The United States Pharmacopeial Convention, USA, 2000.
17. T. Pongjanyakul, A. Priprem, P. Chitropas, and S. Puttipipatkhachorn. Effect of polysulfonate resins and direct compression fillers on multiple-unit sustained-release dextromethorphan resinate tablets. AAPS PharmSciTech. 6: Article 28 (2005).
18. P. R. Katikaneni, S. M. Upadrashta, S. H. Neau, and A. K. Mitra. Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int. J. Pharm. 123:119-125 (1995).
19. A. Nokhodchi, M. H. Rubinstein, and J. L. Ford. The effect of particle size and viscosity grade on the compaction properties of hydroxypropylmethylcellulose 2208. Int. J. Pharm. 126:189-197 (1995).
20. G. Alderbon. Particle dimensions. In G. Alderborn, and C. Nystrom (eds.), Pharmaceutical Powder Compaction Technology, Marcel Dekker, New York, 1996, pp. 245-282.
21. W. Prapaitrakul, and C. W. Whitworth. Compression of microcapsule II: effect of excipients and pressure on physical properties. Drug Dev. Ind. Pharm. 16:1427-1434 (1990).
22. M. Riippi, O. Antikainen, T. Niskanen, and J. Yliruusi. The effect of compression force on surface structure, crushing strength, friability and disintegration time of erythromycin acistrate tablets. Eur. J. Pharm. Biopharm. 46:339-345 (1998).
23. P. Akkaramongkolporn, P. Kulvanich, and M. Pathipvanich. Preparation and in vitro release of dual-drug resinates containing equivalent content dextromethorphan and diphenhydramine. Drug Dev. Ind. Pharm. 32:483-496 (2006).
24. A. R. Rajabi-Siahboomi, R. W. Bowtell, P. Mansfield, A. Henderson, M. C. Davies, and C. D. Melia. Structure and behavior in hydrophilic matrix sustained-release dosage forms: 2. NMR-imaging studies of dimensional changes in the gel layer and core of HPMC tablets undergoing hydration. J. Control. Release. 31:121-128 (1994).
25. O. Chambin, D. Champion, C. Debray, M. H. Rochat-Gonthier, M. L. Meste, and Y. Pourcelot. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J. Control Release. 95:101-108 (2004).
26. P. Akkaramongkolporn, K. Terada, and E. Yonemochi. Molecular properties of propranolol hydrochloride prepared as drug-resin complexes. Drug Dev. Ind. Pharm. 27:359-364 (2001).
27. A. Purnima, P. Namita, and W. Anita. Indion 414 as superdisintegrant in formulation of mouth dissolve tablets. Indian J. Pharm. Sci. 68:117-119 (2006).
28. K. E. Ogger, C. Noory, J. Gabay, V. P. Shah, and J. P. Skelly. Dissolution profiles of resin-based oral suspensions. Pharm. Technol. 9:84-91 (1991).
29. P. Russel. An introduction to ion-exchange resin, Heyden, London, 1970.
30. T. Pongjanyakul, S. Prakongpan, U. Rungsardthong, P. Chancham, and A. Priprem. Characteristics and in vitro release of dextromethorphan resinates. Powder Technol. 152:100-106 (2005).
31. C. E. Harland. Ion exchange: Theory and practice, Royal Society of Chemistry, UK, 1994.
32. N. Kavanagh, and O. I. Corrigan. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices-influence of agitation rate and dissolution medium composition. Int. J. Pharm. 279:141-152 (2004).